These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 20367287

  • 1. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
    Zhu AX.
    Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
    [Abstract] [Full Text] [Related]

  • 2. Novel inhibitors in development for hepatocellular carcinoma.
    Wörns MA, Galle PR.
    Expert Opin Investig Drugs; 2010 May; 19(5):615-29. PubMed ID: 20374038
    [Abstract] [Full Text] [Related]

  • 3. Targeted therapy of hepatocellular cancer.
    Wysocki PJ.
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [Abstract] [Full Text] [Related]

  • 4. Systemic treatment of hepatocellular carcinoma: dawn of a new era?
    Zhu AX.
    Ann Surg Oncol; 2010 May; 17(5):1247-56. PubMed ID: 20405329
    [Abstract] [Full Text] [Related]

  • 5. The present and the future landscape of treatment of advanced hepatocellular carcinoma.
    Rimassa L, Santoro A.
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S273-80. PubMed ID: 20547314
    [Abstract] [Full Text] [Related]

  • 6. Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.
    Kim HY, Park JW.
    Dig Dis; 2011 Jul; 29(3):303-9. PubMed ID: 21829021
    [Abstract] [Full Text] [Related]

  • 7. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?
    Finn RS.
    Clin Cancer Res; 2010 Jan 15; 16(2):390-7. PubMed ID: 20068087
    [Abstract] [Full Text] [Related]

  • 8. Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials.
    Zhang T, Ding X, Wei D, Cheng P, Su X, Liu H, Wang D, Gao H.
    Anticancer Drugs; 2010 Mar 15; 21(3):326-32. PubMed ID: 20016366
    [Abstract] [Full Text] [Related]

  • 9. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.
    Kudo M, Ueshima K.
    Oncology; 2010 Jul 15; 78 Suppl 1():154-66. PubMed ID: 20616599
    [Abstract] [Full Text] [Related]

  • 10. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
    Yau T, Pang R, Chan P, Poon RT.
    Expert Opin Pharmacother; 2010 Sep 15; 11(13):2187-98. PubMed ID: 20707757
    [Abstract] [Full Text] [Related]

  • 11. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R, Chen XP, Dagher L, Venook AP.
    Oncologist; 2010 Sep 15; 15 Suppl 4():42-52. PubMed ID: 21115580
    [Abstract] [Full Text] [Related]

  • 12. Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
    Kudo M.
    Dig Dis; 2011 Sep 15; 29(3):289-302. PubMed ID: 21829020
    [Abstract] [Full Text] [Related]

  • 13. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L, Santoro A.
    Expert Rev Anticancer Ther; 2009 Jun 15; 9(6):739-45. PubMed ID: 19496710
    [Abstract] [Full Text] [Related]

  • 14. Systemic therapies in hepatocellular carcinoma.
    Wörns MA, Weinmann A, Schuchmann M, Galle PR.
    Dig Dis; 2009 Jun 15; 27(2):175-88. PubMed ID: 19546557
    [Abstract] [Full Text] [Related]

  • 15. Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives.
    Zhu AX.
    Semin Oncol; 2012 Aug 15; 39(4):493-502. PubMed ID: 22846866
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine kinase inhibitors to treat liver cancer.
    Huynh H.
    Expert Opin Emerg Drugs; 2010 Mar 15; 15(1):13-26. PubMed ID: 20128706
    [Abstract] [Full Text] [Related]

  • 17. Novel molecular therapies in hepatocellular carcinoma.
    Faivre S, Bouattour M, Raymond E.
    Liver Int; 2011 Jan 15; 31 Suppl 1():151-60. PubMed ID: 21205154
    [Abstract] [Full Text] [Related]

  • 18. Molecularly targeted therapy in hepatocellular carcinoma.
    Huynh H.
    Biochem Pharmacol; 2010 Sep 01; 80(5):550-60. PubMed ID: 20371362
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma.
    Kuzuya T, Tsuchiya K, Izumi N.
    Gan To Kagaku Ryoho; 2010 Oct 01; 37(10):1883-86. PubMed ID: 21069944
    [No Abstract] [Full Text] [Related]

  • 20. Sorafenib: delivering a targeted drug to the right targets.
    Flaherty KT.
    Expert Rev Anticancer Ther; 2007 May 01; 7(5):617-26. PubMed ID: 17492926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.